Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy

被引:94
作者
Kanesaki, Y
Suzuki, D
Uehara, G
Toyoda, M
Katoh, T
Sakai, H
Watanabe, T
机构
[1] Fukushima Med Univ, Sch Med, Dept Internal Med 3, Fukushima 9601295, Japan
[2] Tokai Univ, Dept Internal Med, Isehara, Kanagawa, Japan
关键词
mesangial matrix; extra vessels; in situ hybridization; diabetic nephropathy;
D O I
10.1053/j.ajkd.2004.09.020
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In diabetic nephropathy (DN) small vessels are frequently observed around the glomerular vascular pole in addition to normal afferent and efferent arterioles; this is regarded as neovascularization. Because vascular endothelial growth factor (VEGF) promotes vascular generation, the authors investigated the relationship between glomerular VEGF gene expression and structural glomerular changes in the early stage of human DN. Methods: Kidney specimens were obtained from 18 type 2 DN patients by open renal biopsy. Additional vessels were distinguished by light microscopy as either afferent or efferent arterioles. Glomerular VEGF messenger RNA expression was determined by using in situ hybridization. The mesangial matrix area was quantified, and the ratio of the mesangial matrix area to the whole glomerular area was calculated to determine the mesangial matrix index (MMI). Results: There were significantly more glomeruli with extra vessels in DN than in normal kidneys. The degree of neovascularization was significantly increased in DN and correlated with the magnitude of VEGF messenger RNA expression (r(2) = 0.46, P = 0.010) and MMI (r(2) = 0.45, P = 0.0093). Conclusion: These findings suggest that glomerular VEGF maybe involved in structural changes inhuman DN at an early stage.
引用
收藏
页码:288 / 294
页数:7
相关论文
共 19 条
  • [1] VASCULAR-PERMEABILITY FACTOR MESSENGER-RNA AND PROTEIN EXPRESSION IN HUMAN KIDNEY
    BROWN, LF
    BERSE, B
    TOGNAZZI, K
    MANSEAU, EJ
    VANDEWATER, L
    SENGER, DR
    DVORAK, HF
    ROSEN, S
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (06) : 1457 - 1461
  • [2] Role of vascular endothelial growth factor in diabetic nephropathy
    Cha, DR
    Kim, NH
    Yoon, JW
    Jo, SK
    Cho, WC
    Kim, HK
    Won, NH
    [J]. KIDNEY INTERNATIONAL, 2000, 58 : S104 - S112
  • [3] Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
    Cooper, ME
    Vranes, D
    Youssef, S
    Stacker, SA
    Cox, AJ
    Rizkalla, B
    Casley, DJ
    Bach, LA
    Kelly, DJ
    Gilbert, RE
    [J]. DIABETES, 1999, 48 (11) : 2229 - 2239
  • [4] DAVID OB, 2002, CANCER RES, V62, P4123
  • [5] De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993
  • [6] GLOMERULAR-LESIONS IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND MICROALBUMINURIA
    KANAUCHI, M
    ISHIHARA, K
    NISHIOKA, H
    NISHIURA, K
    DOHI, K
    [J]. INTERNAL MEDICINE, 1993, 32 (10) : 753 - 757
  • [7] Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells
    Kim, NH
    Jung, HH
    Cha, DR
    Choi, DS
    [J]. JOURNAL OF ENDOCRINOLOGY, 2000, 165 (03) : 617 - 624
  • [8] Steroid therapy reduces mesangial matrix accumulation in advanced IgA nephropathy
    Kuriki, M
    Asahi, K
    Asano, K
    Sakurai, K
    Eiro, M
    Suzuki, H
    Watanabe, K
    Katoh, T
    Watanabe, T
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (07) : 1311 - 1315
  • [9] Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione
    Onozaki, A
    Midorikawa, S
    Sanada, H
    Hayashi, Y
    Baba, T
    Katoh, T
    Watanabe, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (01) : 24 - 29
  • [10] ADVANCED DIABETIC GLOMERULOPATHY - QUANTITATIVE STRUCTURAL CHARACTERIZATION OF NONOCCLUDED GLOMERULI
    OSTERBY, R
    GUNDERSEN, HJG
    NYBERG, G
    AURELL, M
    [J]. DIABETES, 1987, 36 (05) : 612 - 619